Results for the six months ended 30 September 2022

24 November 2022Read more

Investor Presentation covering Interim Results

24 November 2022Read more

Partnership with Moredun Research Institute – Poultry Red Mite Vaccine

11 July 2022Read more

ECO Animal Health Group plc in partnership with Imperial College London

30 June 2022Read more

ECO RECIEVES TWO NEW MARKETING AUTHORISATIONS FOR AIVLOSIN® IN CHINA

11 April 2022Read more

New Aivlosin® WSG M. hyopneumoniae claim in USA & Canada

13 January 2021Read more

Brazilian Marketing Authorisation for Swine Vaccine Circo/MycoGard®

7 January 2021Read more

ECO signs two PRRSV vaccine development and licencing deals

15 October 2020Read more

European marketing authorisation for Aivlosin® WSG in pigs for treatment and metaphylaxis of M. hyopneumoniae

29 June 2020Read more

Marketing authorisation in Indonesia received for Aivlosin®/Valosin® WSG in chickens laying eggs

30 January 2020Read more

ECO and The Pirbright Institute sign second poultry vaccine development licensing deal

11 September 2019Read more

ECO and The Pirbright Institute sign novel poultry biopharmaceutical development licensing deal

4 September 2019Read more

ECO and Ghent University Sign Poultry Vaccine Development Licencing Deal

13 February 2019Read more

ECO and University of Georgia sign second poultry vaccine development licencing deal for Mycoplasma synoviae vaccine

5 February 2019Read more

ECO and Agrinnovation (Yissum) LP sign swine antimicrobial novel formulation development & licensing deal

3 December 2018Read more

ECO and University of Georgia sign poultry vaccine development licencing deal

19 November 2018Read more